SELLAS Life Sciences Group, Inc. (SLS)
14.32
-1.14
(-7.34%)
USD |
NASDAQ |
Aug 24, 16:00
14.32
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Enterprise Value : 2.984B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.984B |
| August 20, 2026 | 2.568B |
| August 19, 2026 | 2.659B |
| August 18, 2026 | 2.507B |
| August 17, 2026 | 2.487B |
| August 14, 2026 | 2.443B |
| August 13, 2026 | 2.358B |
| August 12, 2026 | 2.239B |
| August 11, 2026 | 2.093B |
| August 10, 2026 | 2.091B |
| August 07, 2026 | 2.287B |
| August 06, 2026 | 2.225B |
| August 05, 2026 | 2.257B |
| August 04, 2026 | 2.247B |
| August 03, 2026 | 2.128B |
| July 31, 2026 | 1.884B |
| July 30, 2026 | 1.940B |
| July 29, 2026 | 1.902B |
| July 28, 2026 | 1.900B |
| July 27, 2026 | 2.050B |
| July 24, 2026 | 2.148B |
| July 23, 2026 | 2.354B |
| July 22, 2026 | 2.301B |
| July 21, 2026 | 2.467B |
| July 20, 2026 | 2.381B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.526B |
| July 16, 2026 | 2.235B |
| July 15, 2026 | 2.445B |
| July 14, 2026 | 2.566B |
| July 13, 2026 | 2.411B |
| July 10, 2026 | 2.439B |
| July 09, 2026 | 2.590B |
| July 08, 2026 | 2.641B |
| July 07, 2026 | 2.588B |
| July 06, 2026 | 2.677B |
| July 02, 2026 | 2.887B |
| July 01, 2026 | 2.542B |
| June 30, 2026 | 2.843B |
| June 29, 2026 | 2.695B |
| June 26, 2026 | 2.140B |
| June 25, 2026 | 1.803B |
| June 24, 2026 | 1.556B |
| June 23, 2026 | 1.538B |
| June 22, 2026 | 1.440B |
| June 18, 2026 | 1.353B |
| June 17, 2026 | 1.301B |
| June 16, 2026 | 1.259B |
| June 15, 2026 | 1.295B |
| June 12, 2026 | 1.314B |
| June 11, 2026 | 1.299B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Savara, Inc. | 1.006B |
| Lite Strategy, Inc. | 27.25M |
| AbbVie, Inc. | 532.50B |
| Marker Therapeutics, Inc. | 11.25M |
| Rezolute, Inc. | 370.97M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.605M |
| Total Expenses (Quarterly) | 9.605M |
| EPS Diluted (Quarterly) | -0.0508 |
| Earnings Yield | -1.48% |
| Normalized Earnings Yield | -1.481 |